Actively Recruiting
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer
Led by Ludwig-Maximilians - University of Munich · Updated on 2018-10-19
60
Participants Needed
1
Research Sites
428 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective observational study to evaluate the Quality of life based on standardized EORTC questionaires as well as toxicities, functional and oncological outcomes in patients treated with neoadjuvant or definitive chemoradiation for esophageal Cancer.
CONDITIONS
Official Title
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically proven esophageal cancer (SCC or adenocarcinoma) without distant metastases except supraclavicular nodes
- Indication for neoadjuvant or definitive chemoradiation using cisplatin/5-FU or carboplatin/paclitaxel with curative intent
- Age 18 years or older
- Written informed consent
- Ability to answer standardized questionnaires as determined by the treating physician
You will not qualify if you...
- Age under 18 years
- Treatment with palliative intent
- Presence of distant metastases except supraclavicular nodes
- Second malignancy
- Prior systemic treatment for esophageal cancer
- Participation in an interventional study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Radiation Oncology, University Hospital, LMU Munich
Munich, Bavaria, Germany, 81377
Actively Recruiting
Research Team
F
Falk Roeder, MD
CONTACT
F
Franziska Walter, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here